Home
|
Site Map
|
Add to Favorites Link
|
Send page to a Friend
|
Contact us
About Us
Products
Research and Development
Publications and Press
Clinical Trials
Latest News
Contact us
Profile
Our mission
Partnerships
NGO and support groups
Contact Us
Medicines
Product licencing policy
Collaborate with us
Current projects
Future projects
A new model for pharmaceuticals
Scientific papers
In the news
Press release
Clinical reports
Projects
Todos os Conteúdos
Animal models of cancer - Effect of P-MAPA on renal carcinoma (RENCA)
Animal Models of Cancer - Antitumoral Effect of P-MAPA on Mammary Carcinoma and Plasmacitoma
Animal models of cancer - Effect on Ehrlich ascites tumor-bearing
Human Immunodeficiency Virus (HIV) - In vitro antiviral activity
Toxicity and Safety - Plasmatic concentration
Toxicity and Safety -Bioavaliabilty and target organs
Animal models of cancer - Walker 256 carcinosarcoma
Toxicity and Safety -Toxicity in vitro
Toxicity and Safety -Toxicity in Animals - LD 50 and acute toxicity in mice
Toxicity and Safety -Toxicity in Animals -12week multiple-dose toxicity
[
First
] [
Previous
] [
1
] [
2
] [
3
] [
4
] [
5
] [
6
] [
7
] [
8
] [
9
] [
Next
] [
Last
]
Privacy Policy
|
Legal
|
copyright@2.006-farmabrasilis- all rights reserved